The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease
Chagas disease is a neglected tropical disease caused by the flagellated protozoa <i>Trypanosome cruzi</i>. This illness affects to almost 8-12 million people worldwide, however, is endemic to Latin American countries. It is mainly vectorially transmitted by insects of the Triatominae fa...
Saved in:
Main Authors: | Edio Maldonado (Author), Diego A. Rojas (Author), Fabiola Urbina (Author), Aldo Solari (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T. cruzi DNA polymerase beta (Tcpolβ) is phosphorylated in vitro by CK1, CK2 and TcAUK1 leading to the potentiation of its DNA synthesis activity.
by: Edio Maldonado, et al.
Published: (2021) -
Aging Hallmarks and the Role of Oxidative Stress
by: Edio Maldonado, et al.
Published: (2023) -
Endogenous overexpression of an active phosphorylated form of DNA polymerase β under oxidative stress in Trypanosoma cruzi.
by: Diego A Rojas, et al.
Published: (2018) -
Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.
by: Clara Crespillo-Andújar, et al.
Published: (2022) -
The costs of preventing and treating chagas disease in Colombia.
by: Marianela Castillo-Riquelme, et al.
Published: (2008)